<p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>

Guillaume Beziat, Loïc Ysebaert

Open source

DOI
10.2147/ott.s228342
Published
2020-06
Container
OncoTargets and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s228342,
  title = {\<p\>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data\</p\>},
  author = {Guillaume Beziat and Loïc Ysebaert},
  year = {2020},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s228342},
  url = {https://doi.org/10.2147/ott.s228342}
}

RIS

TY  - JOUR
TI  - <p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>
AU  - Guillaume Beziat
AU  - Loïc Ysebaert
PY  - 2020
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s228342
UR  - https://doi.org/10.2147/ott.s228342
ER  - 

APA

Beziat, G., & Ysebaert, L. (2020). <p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>. OncoTargets and Therapy. https://doi.org/10.2147/ott.s228342

Source records